These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21390009)

  • 1. Greg Winter.
    Winter G
    Nat Biotechnol; 2011 Mar; 29(3):190. PubMed ID: 21390009
    [No Abstract]   [Full Text] [Related]  

  • 2. Five more years of Nature Biotechnology research.
    Baker M; DeFrancesco L
    Nat Biotechnol; 2011 Mar; 29(3):221-7. PubMed ID: 21390024
    [No Abstract]   [Full Text] [Related]  

  • 3. Wrong numbers?
    Nat Biotechnol; 2010 Aug; 28(8):761. PubMed ID: 20697382
    [No Abstract]   [Full Text] [Related]  

  • 4. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech in Italy.
    Biotechnol J; 2007 Mar; 2(3):298-300. PubMed ID: 17354217
    [No Abstract]   [Full Text] [Related]  

  • 7. 454 life sciences: illuminating the future of genome sequencing and personalized medicine.
    Patrick K
    Yale J Biol Med; 2007 Dec; 80(4):191-4. PubMed ID: 18449390
    [No Abstract]   [Full Text] [Related]  

  • 8. Growing pains for biopharmaceuticals.
    Ashton G
    Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech R&D still reeling.
    Lawrence S
    Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
    [No Abstract]   [Full Text] [Related]  

  • 10. Anthony Coyle.
    Coyle A
    Nat Biotechnol; 2011 Mar; 29(3):187. PubMed ID: 21390006
    [No Abstract]   [Full Text] [Related]  

  • 11. Elias Zerhouni.
    Zerhouni E
    Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
    [No Abstract]   [Full Text] [Related]  

  • 12. An audience with… Henry Chesbrough. Interview by Asher Mullard.
    Chesbrough H
    Nat Rev Drug Discov; 2013 May; 12(5):338-9. PubMed ID: 23598507
    [No Abstract]   [Full Text] [Related]  

  • 13. Legal and social aspects of biotechnology in Poland.
    Twardowski T
    Acta Biochim Pol; 2005; 52(3):III-V. PubMed ID: 16475253
    [No Abstract]   [Full Text] [Related]  

  • 14. Value creation and sharing among universities, biotechnology and pharma.
    Edwards MG; Murray F; Yu R
    Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
    [No Abstract]   [Full Text] [Related]  

  • 15. Innovation for life science innovators.
    Cancer Discov; 2012 Dec; 2(12):OF1. PubMed ID: 23230190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting report: Symbiosis in Barcelona.
    Janssens B
    Biotechnol J; 2008 Jan; 3(1):23-7. PubMed ID: 18200494
    [No Abstract]   [Full Text] [Related]  

  • 17. Crossing the line.
    Blaivas JG
    Neurourol Urodyn; 2002; 21(3):185. PubMed ID: 11948709
    [No Abstract]   [Full Text] [Related]  

  • 18. Study critiques corporate control of trials.
    Niiler E
    Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659
    [No Abstract]   [Full Text] [Related]  

  • 19. Life sciences firms cheer unlocking of National Health Service.
    Hodgson J
    Nat Biotechnol; 2011 Jul; 29(7):560. PubMed ID: 21747369
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.